Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild Moderate”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT05594667
What this trial is testing

Effect of SSRIs on Response to Psilocybin Therapy

Who this might be right for
DepressionMajor Depressive DisorderMild Depression+2 more
Cybin Therapeutics Inc.
Early research (Phase 1)Study completedNCT00636207
What this trial is testing

Evaluate the Safety, Tolerability, and Pharmacokinetics of Inhaled Montelukast (MK-0476) in Participants With Mild or Moderate Asthma (MK-0476-380 AM3)(COMPLETED)

Who this might be right for
Asthma
Organon and Co 46
Not applicableUnknownNCT05260593
What this trial is testing

Effect of Phonophoresis With Vitamin B12 on CTS

Who this might be right for
Carpal Tunnel Syndrome
October 6 University 54
Not applicableStudy completedNCT04265521
What this trial is testing

Study With BioCool Footcare in Subjects With Tinea Pedis Interdigitalis and Heel Cracks, Calluses and/or Dry Feet

Who this might be right for
Foot FungusTineaTinea Pedis+2 more
Biocool AB 25
Not applicableAvailableNCT04657406
What this trial is testing

Expanded Access to Zofin for Patients With COVID-19

Who this might be right for
Covid19Corona Virus InfectionSARS (Severe Acute Respiratory Syndrome)+1 more
ZEO ScientifiX, Inc.
Not applicableEnded earlyNCT05639738
What this trial is testing

Assessment of Clinical, Biological and Biometrological Paramaters in Adult Subjects Suffering From AD

Who this might be right for
Dermatitis, Atopic
Pierre Fabre Dermo Cosmetique 12
Not applicableUnknownNCT03434938
What this trial is testing

IMAGINE Study Protocol

Who this might be right for
Patients (>=60 Years Old) Suffering From Mild-moderate Stroke (Ischemic or Hemorrhagic, Stroke Severity Assessed by NIHSS <16 Points)
Parc Sanitari Pere Virgili 272
Early research (Phase 1)Study completedNCT00002946
What this trial is testing

Penclomedine in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07820046
What this trial is testing

Nitazoxanide as Adjunct Therapy in Mild-to-Moderate Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Tanta University 44
Large-scale testing (Phase 3)Looking for participantsNCT07469800
What this trial is testing

Efficacy and Safety of IBI362 in Hypertensive Patients With Overweight/Obesity

Who this might be right for
OverweightObesityHypertensive
Innovent Biologics (Suzhou) Co. Ltd. 336
Testing effectiveness (Phase 2)Study completedNCT00002501
What this trial is testing

Cyclophosphamide and Filgrastim in Treating Patients With Stage IV, Relapsed, or Refractory Low-Grade Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Alliance for Clinical Trials in Oncology 29
Early research (Phase 1)Study completedNCT00058292
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Northwestern University 44
Large-scale testing (Phase 3)Study completedNCT00112931
What this trial is testing

Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University College, London 462
Testing effectiveness (Phase 2)Study completedNCT02254772
What this trial is testing

A Phase I/II Study of Intratumoral Injection of SD-101

Who this might be right for
Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Grade 1 Follicular Lymphoma+4 more
Robert Lowsky 9
Testing effectiveness (Phase 2)Study completedNCT05076253
What this trial is testing

Efficacy of Ivermectin in COVID-19

Who this might be right for
SafetySARS-CoV2 InfectionIvermectin Poisoning+1 more
Bangkok Metropolitan Administration Medical College and Vajira Hospital 72
Large-scale testing (Phase 3)Looking for participantsNCT07262645
What this trial is testing

Near-infrared Light Therapy Device for Mild-Moderate Alzheimer's Disease (NirsCure-03A)

Who this might be right for
Alzheimer s Disease
Danyang Huichuang Medical Equipment Co., Ltd. 320
Early research (Phase 1)Study completedNCT02379507
What this trial is testing

DEC033 Study Product for Mild to Moderate Eczema An Open-label, Adaptive-design Pilot Study

Who this might be right for
Eczema
Medicus Research, LLC 20
Not applicableEnded earlyNCT02649075
What this trial is testing

To Evaluate SBI in the Dietary Management of Mild to Moderate Crohn's Disease

Who this might be right for
Crohn's Disease
Entera Health, Inc 7
Testing effectiveness (Phase 2)Study completedNCT00006019
What this trial is testing

Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer

Who this might be right for
LeukemiaLung CancerLymphoma+3 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT03571620
What this trial is testing

Safety and Efficacy Study of Q301 in Mild to Moderate Adolescents and Adults Atopic Dermatitis Patients

Who this might be right for
Atopic Dermatitis
Qurient Co., Ltd. 258
Next Page